H. SEVİM NALKIRAN Et Al. , "Aberrant expression of low molecular weight proteins associated with response to conventional concurrent chemoradiotherapy treatment and overall survival?," European Association of Neuro-oncology (EANO) 10th meeting , no.14, Marsilya, France, 2012
SEVİM NALKIRAN, H. Et Al. 2012. Aberrant expression of low molecular weight proteins associated with response to conventional concurrent chemoradiotherapy treatment and overall survival?. European Association of Neuro-oncology (EANO) 10th meeting , (Marsilya, France).
SEVİM NALKIRAN, H., Chung, L., Wheeler, H. R., Baxter, R. C., & McDonald, K. L., (2012). Aberrant expression of low molecular weight proteins associated with response to conventional concurrent chemoradiotherapy treatment and overall survival? . European Association of Neuro-oncology (EANO) 10th meeting, Marsilya, France
SEVİM NALKIRAN, HATİCE Et Al. "Aberrant expression of low molecular weight proteins associated with response to conventional concurrent chemoradiotherapy treatment and overall survival?," European Association of Neuro-oncology (EANO) 10th meeting, Marsilya, France, 2012
SEVİM NALKIRAN, HATİCE S. Et Al. "Aberrant expression of low molecular weight proteins associated with response to conventional concurrent chemoradiotherapy treatment and overall survival?." European Association of Neuro-oncology (EANO) 10th meeting , Marsilya, France, 2012
SEVİM NALKIRAN, H. Et Al. (2012) . "Aberrant expression of low molecular weight proteins associated with response to conventional concurrent chemoradiotherapy treatment and overall survival?." European Association of Neuro-oncology (EANO) 10th meeting , Marsilya, France.
@conferencepaper{conferencepaper, author={HATİCE SEVİM NALKIRAN Et Al. }, title={Aberrant expression of low molecular weight proteins associated with response to conventional concurrent chemoradiotherapy treatment and overall survival?}, congress name={European Association of Neuro-oncology (EANO) 10th meeting}, city={Marsilya}, country={France}, year={2012}}